Search results
Alvotech. Our approach. We believe that a vertically integrated approach, from cell line development through fill and finish manufacturing, gives us the control, scale and speed needed to achieve our mission.
Join our team. Here at Alvotech, we want our employees to feel inspired in their careers and challenged by interesting and meaningful work. That’s why we are proud of our purpose-driven culture and the science we invest in.
Alvotech. Better Access. Better Lives. We are led by science, driven by passion, and committed to biosimilars. We are continually evaluating additional pipeline opportunities to bring a strategic and robust selection of treatment options to patients around the world.
Alvotech is a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities.
Jun 15, 2022 · Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the U.S., Europe, Japan, China, and other Asian...
Jan 10, 2024 · Approval for the Uzpruvo biosimilar is based on comprehensive package comprising analytical, non-clinical and clinical similarity data, including the AVT04-GL-301 confirmatory comparative efficacy and safety clinical trial in patients with moderate to severe chronic plaque-type psoriasis.
Apr 24, 2024 · In November 2023 Alvotech announced positive topline results from a pharmacokinetic study (NCT05632211) for AVT05, which assessed the pharmacokinetics, safety, and tolerability of AVT05 compared to EU approved Simponi and US-licensed Simponi in 336 healthy adult subjects.
Guidelines for Alvotech applicants. Available positions at Alvotech are posted on our Career page and applications must be made via our online recruitment system. Applications should be submitted in English.
Alvotech | 27,566 followers on LinkedIn. Better Access. Better Lives. | Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the ...
It is our aim to broaden the availability and accessibility of these important biologic medicines to patients around the world by developing and manufacturing high-quality, cost-competitive biosimilars.
